ISOAPI-D™ – Deuterated Reagents for Pharmaceuticals
ISOAPI-D™: Built Specifically for the Next Generation of Deuterated Reagents in Pharmaceutical Development
ISOAPI-D combines CIL’s decades of expertise and global manufacturing footprint with a diversified, secure supply chain, premium deuterated materials, and rigorous quality assurance. Whether you’re developing novel APIs or optimizing existing drug candidates, ISOAPI-D empowers your team with smarter, stronger therapeutic foundations. Our solutions deliver proven advantages — extended half-life, improved metabolic profiles, and more efficient production — backed by full traceability and compliance with the highest industry standards. Explore how ISOAPI-D can help you accelerate API innovation, minimize risk, and deliver new therapeutic possibilities with confidence.










